Goldman Sachs
VSTM icon

Goldman Sachs’s Verastem VSTM Stock Holding History

Goldman Sachs’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8,333
Closed -$134K – 5586
2019
Q4 		$134K Buy
+8,333
New +$120K ﹤0.01% 4999

Other funds holding VSTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs's VSTM Position: Q2 2026 in Review

Goldman Sachs increased its Verastem (VSTM) stake by 83% in Q2 2026, buying an estimated $5.99M and bringing the position to 2,721,178 shares worth $10.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3195.

Goldman Sachs first reported a position in VSTM in Q2 2013 and has held it in 46 quarters since. The position peaked at $11.5M in Q4 2025. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Goldman Sachs held 2,721,178 shares of Verastem worth $10.4M as of Q2 2026.
  • Goldman Sachs bought 1,237,175 Verastem shares in Q2 2026, an estimated $5.99M.
  • Verastem made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3195 holding.
  • Goldman Sachs first reported a position in Verastem in Q2 2013 and has held it in 46 quarters since.
  • Goldman Sachs's Verastem position peaked at $11.5M in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.